Commonwealth Equity Services, LLC Supernus Pharmaceuticals, Inc. Transaction History
Commonwealth Equity Services, LLC
- $68.4 Billion
- Q4 2024
A detailed history of Commonwealth Equity Services, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 9,796 shares of SUPN stock, worth $313,374. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,796
Previous 10,250
4.43%
Holding current value
$313,374
Previous $320,000
10.63%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding SUPN
# of Institutions
303Shares Held
60.7MCall Options Held
22.3KPut Options Held
6K-
Black Rock Inc. New York, NY10.4MShares$332 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.15MShares$197 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY4.84MShares$155 Million2.47% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.88MShares$92.1 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C32.63MShares$84.1 Million0.11% of portfolio
About SUPERNUS PHARMACEUTICALS, INC.
- Ticker SUPN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 53,495,300
- Market Cap $1.71B
- Description
- Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...